Delivery Order SPE2DB20D2014-SPE2DB24FA38U
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,885,038 units of 20 mg Atorvastatin tablets, a cardiovascular medication, with a ceiling value of $2,259.75. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,565,404,327 units of Atorvastatin 20 mg tablets. The contract, valued at $3,596.23, was awarded by the Defense Logistics Agency (DLA) on August 9, 2024, with a completion date of August 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen...
- This federal contract award, valued at $1,080.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4560830821 Atorvastatin 20 mg tablets. The contract is a delivery order with a firm fixed price and has a completion date of May 5, 2023. The award does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
- This federal contract award, valued at $3,155.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 40 mg tablets in quantities of 1,000 to support military healthcare programs. This is a delivery order contract with a firm fixed price arrangement. The contract has an ultimate completion date of July 9, 2024 and was awarded on July 8, 2024....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.94 delivery order contract is for the supply of 4,568,190,570 units of the prescription medication Atorvastatin 80 mg tablets. The award is not set aside and is a firm fixed price contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,627.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,601 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 26, 2023 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a...
- This federal contract award, valued at $1,668.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,600 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,301.26 firm fixed-price delivery order is for the supply of 1,000 units of atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of January 19, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 80 mg Atorvastatin tablets. The $2,088.50 firm-fixed-price contract has an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities, including...
- This federal contract award, valued at $1,628.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,405,913 units of Atorvastatin 80 mg tablets, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price, and has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA38UDelivery Order
This federal contract award, valued at $2,337.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 20 mg tablets in quantities of 1,000 per order, with a completion date of November 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience in federal healthcare procurement and its ability to efficiently deliver a wide array of critical medical commodities make it a valuable vendor for the DLA and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/21/23 |